Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections
Ronald S. Duman
Dialogues in Clinical Neuroscience (2014) Vol. 16, Iss. 1, pp. 11-27
Open Access | Times Cited: 235

Showing 1-25 of 235 citing articles:

BDNF – a key transducer of antidepressant effects
Carl Björkholm, Lisa M. Monteggia
Neuropharmacology (2015) Vol. 102, pp. 72-79
Open Access | Times Cited: 825
Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders
Ebrahim Haroon, Andrew H. Miller, Gerard Sanacora
Neuropsychopharmacology (2016) Vol. 42, Iss. 1, pp. 193-215
Open Access | Times Cited: 444
Casting a Wide Net: Role of Perineuronal Nets in Neural Plasticity
Barbara A. Sorg, Sabina Berretta, Jordan M. Blacktop, et al.
Journal of Neuroscience (2016) Vol. 36, Iss. 45, pp. 11459-11468
Open Access | Times Cited: 399
Gut Microbiota and the Neuroendocrine System
Aitak Farzi, Esther E. Fröhlich, Peter Holzer
Neurotherapeutics (2018) Vol. 15, Iss. 1, pp. 5-22
Open Access | Times Cited: 388
Dendritic Spines in Depression: What We Learned from Animal Models
Hui Qiao, Ming-Xing Li, Chang Xu, et al.
Neural Plasticity (2016) Vol. 2016, pp. 1-26
Open Access | Times Cited: 383
Treatment resistant depression: A multi-scale, systems biology approach
Huda Akil, Joshua A. Gordon, René Hen, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 84, pp. 272-288
Open Access | Times Cited: 382
Brain-Derived Neurotrophic Factor, Depression, and Physical Activity: Making the Neuroplastic Connection
Cristy Phillips
Neural Plasticity (2017) Vol. 2017, pp. 1-17
Open Access | Times Cited: 365
The Role of BDNF on Neural Plasticity in Depression
Tao Yang, Zheng Nie, Haifeng Shu, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 305
Ketamine Treatment and Global Brain Connectivity in Major Depression
Chadi G. Abdallah, Lynnette A. Averill, Katherine A. Collins, et al.
Neuropsychopharmacology (2016) Vol. 42, Iss. 6, pp. 1210-1219
Open Access | Times Cited: 271
Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity
Danielle M. Gerhard, Eric S. Wohleb, Ronald S. Duman
Drug Discovery Today (2016) Vol. 21, Iss. 3, pp. 454-464
Open Access | Times Cited: 266
Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs
Elena Dale, Benny Bang‐Andersen, Connie Sánchez
Biochemical Pharmacology (2015) Vol. 95, Iss. 2, pp. 81-97
Open Access | Times Cited: 214
The neuropsychopharmacology of cannabis: A review of human imaging studies
Michael Bloomfield, Chandni Hindocha, Sebastian F Green, et al.
Pharmacology & Therapeutics (2018) Vol. 195, pp. 132-161
Open Access | Times Cited: 210
Brain-gut-microbiota axis: challenges for translation in psychiatry
John R. Kelly, Gerard Clarke, John F. Cryan, et al.
Annals of Epidemiology (2016) Vol. 26, Iss. 5, pp. 366-372
Closed Access | Times Cited: 188
Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naïve and “depressed” mice exposed to chronic mild stress
Anthony Franceschelli, Jonathon Sens, Samantha Herchick, et al.
Neuroscience (2015) Vol. 290, pp. 49-60
Open Access | Times Cited: 185
Pharmacological approaches to the challenge of treatment-resistant depression
Dawn F. Ionescu, Jerrold F. Rosenbaum, Jonathan E. Alpert
Dialogues in Clinical Neuroscience (2015) Vol. 17, Iss. 2, pp. 111-126
Open Access | Times Cited: 185
Disinhibition of CA1 pyramidal cells by low-dose ketamine and other antagonists with rapid antidepressant efficacy
Allie J. Widman, Lori L. McMahon
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 13
Open Access | Times Cited: 180
NMDA Receptor Activation-Dependent Antidepressant-Relevant Behavioral and Synaptic Actions of Ketamine
Panos Zanos, Kyle A. Brown, Polymnia Georgiou, et al.
Journal of Neuroscience (2023) Vol. 43, Iss. 6, pp. 1038-1050
Open Access | Times Cited: 58
Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry
Jesse E. Hanson, Hongjie Yuan, Riley E. Perszyk, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 51-66
Open Access | Times Cited: 54
Ketamine and phencyclidine: the good, the bad and the unexpected
David Lodge, Marion Mercier
British Journal of Pharmacology (2015) Vol. 172, Iss. 17, pp. 4254-4276
Open Access | Times Cited: 166
Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression
Wenxue Liu, Jing Wang, Ze-Min Xie, et al.
Psychopharmacology (2015) Vol. 233, Iss. 3, pp. 405-415
Closed Access | Times Cited: 140
Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice
Juanjuan Tang, Wenda Xue, Baomei Xia, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 133
Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications
Ebrahim Haroon, Andrew H. Miller
Current topics in behavioral neurosciences (2016), pp. 173-198
Closed Access | Times Cited: 129
Alterations in brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in the brain regions of a learned helplessness rat model and the antidepressant effects of a TrkB agonist and antagonist
Yukihiko Shirayama, Chun Yang, Jichun Zhang, et al.
European Neuropsychopharmacology (2015) Vol. 25, Iss. 12, pp. 2449-2458
Closed Access | Times Cited: 128
Transcranial and systemic photobiomodulation for major depressive disorder: A systematic review of efficacy, tolerability and biological mechanisms
Marco Antônio Caldieraro, Paolo Cassano
Journal of Affective Disorders (2018) Vol. 243, pp. 262-273
Closed Access | Times Cited: 119
Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants
Todd D. Gould, Carlos A. Zarate, Scott M. Thompson
The Annual Review of Pharmacology and Toxicology (2018) Vol. 59, Iss. 1, pp. 213-236
Open Access | Times Cited: 117
Page 1 - Next Page

Scroll to top